Japan’s medical device market is highly dependent on imports, especially sophisticated products such as pacemakers and surgical robotic systems.

From being a market with long approval times, new regulatory procedures have resulted in shorter approval times in recent years. According to Nikkei Asia, the Japanese government is now planning to cut the need for regulatory approval to update AI software used as a medical device or SaMD.

This development will facilitate for EU companies considering entering the Japanese market. The increasing need for automation in the Japanese healthcare industry, could offer EU companies market opportunities in various segments including robot surgery.

The webinar targets EU small- and medium-sized companies seeking to find opportunities in the Japanese medical device market.

FOR MORE INFORMATION & TO REGISTER: CLICK HERE

Please keep in mind that this webinar is only accessible to EU companies which are registered to the EU Business in Japan website: http://www.eubusinessinjapan.eu/user/register